{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:07:16Z","timestamp":1765357636583},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,11]]},"DOI":"10.7759\/cureus.64367","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T04:03:09Z","timestamp":1720756989000},"source":"Crossref","is-referenced-by-count":2,"title":["Catastrophic Antiphospholipid Syndrome: A Life-Threatening Condition"],"prefix":"10.7759","author":[{"given":"Sonal","family":"Prasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edsel","family":"Embry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loui","family":"Abdelghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Antiphospholipid Syndrome","author":"Bustamante JG","year":"2024","unstructured":"Bustamante JG, Goyal A, Rout P, et al.. Antiphospholipid Syndrome. StatPearls, Treasure Island, FL; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/immuno4010001","article-title":"Catastrophic antiphospholipid syndrome: a review","volume":"4","author":"Siniscalchi C","year":"2024","unstructured":"Siniscalchi C, Basaglia M, Riva M, Meschi M, Meschi T, Castaldo G, Di Micco P. Catastrophic antiphospholipid syndrome: a review. Immuno. 2024, 4:1-13. 10.3390\/immuno4010001","journal-title":"Immuno"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010668","article-title":"Catastrophic antiphospholipid syndrome","volume":"25","author":"Bitsadze V","year":"2024","unstructured":"Bitsadze V, Yakubova F, Khizroeva J, et al.. Catastrophic antiphospholipid syndrome. Int J Mol Sci. 2024, 25:668. 10.3390\/ijms25010668","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12860\/jnp.2014.03","article-title":"Catastrophic antiphospholipid syndrome: a clinical review","volume":"3","author":"Nayer A","year":"2014","unstructured":"Nayer A, Ortega LM. Catastrophic antiphospholipid syndrome: a clinical review. J Nephropathol. 2014, 3:9-17. 10.12860\/jnp.2014.03","journal-title":"J Nephropathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\"","volume":"32","author":"Cervera R","year":"2009","unstructured":"Cervera R, Bucciarelli S, Plas\u00edn MA, et al.. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\". J Autoimmun. 2009, 32:240-5. 10.1016\/j.jaut.2009.02.008","journal-title":"J Autoimmun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X13502919","article-title":"Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease","volume":"5","author":"Aguiar CL","year":"2013","unstructured":"Aguiar CL, Erkan D. Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease. Ther Adv Musculoskelet Dis. 2013, 5:305-14. 10.1177\/1759720X13502919","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key082","article-title":"The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients","volume":"57","author":"Rodr\u00edguez-Pint\u00f3 I","year":"2018","unstructured":"Rodr\u00edguez-Pint\u00f3 I, Espinosa G, Erkan D, Shoenfeld Y, Cervera R. The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients. Rheumatology (Oxford). 2018, 57:1264-70. 10.1093\/rheumatology\/key082","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.6.530","article-title":"Long term outcome of catastrophic antiphospholipid syndrome survivors","volume":"62","author":"Erkan D","year":"2003","unstructured":"Erkan D, Asherson RA, Espinosa G, Cervera R, Font J, Piette JC, Lockshin MD. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis. 2003, 62:530-3. 10.1136\/ard.62.6.530","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/271117-catastrophic-antiphospholipid-syndrome-a-life-threatening-condition","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T04:03:13Z","timestamp":1720756993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/271117-catastrophic-antiphospholipid-syndrome-a-life-threatening-condition"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.64367","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,11]]}}}